Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery Via Primary Care
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 672
- 试验地点
- 1
- 主要终点
- Cigarettes smoking
研究概览
简要总结
The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to quit, and preferences for medications for quitting smoking. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •current smoking, defined as 1+ cigarettes/day, for 20+ days out of the last 30 for the last 6+ months
- •enrolled in MyChart or willing to enroll
- •possess a valid e-mail address that is checked daily
- •owner of an iOS or Android smartphone to provide remote CO
- •have a valid mailing address
- •English fluency
排除标准
- •1) Use of an FDA-approved cessation medication in the last 7 days
研究组 & 干预措施
Smoking cessation electronic visit (e-visit)
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking and 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit.
干预措施: Smoking cessation e-visit (Behavioral)
Treatment as usual (TAU)
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
干预措施: Treatment As Usual (Behavioral)
结局指标
主要结局
Cigarettes smoking
时间窗: Month 6
Cigarettes per day reduction greater than 50%
Quit attempts
时间窗: Month 6
Quit attempts since last contact
Seven-day point prevalence abstinence
时间窗: Month 6
Participant has not had a cigarette in the past 7 days
Number of participants who utilized smoking cessation treatment
时间窗: Month 6
Number of participants who utilized smoking cessation treatment since last assessment.
E-visit Adoption
时间窗: Month 6
Patients prescribed a medication who obtain their medication
E-visit Acceptability
时间窗: Month 6
The e-visit will be considered acceptable if the average score on the Acceptability of Intervention Measure (AIM) is greater than or equal to 4.
Number of participants who utilized smoking cessation treatment
时间窗: Month 1
Number of participants who utilized smoking cessation treatment since last assessment.
Number of participants who utilized smoking cessation treatment
时间窗: Month 3
Number of participants who utilized smoking cessation treatment since last assessment.
Cigarettes smoking
时间窗: Month 1
Cigarettes per day reduction greater than 50%
Cigarettes smoking
时间窗: Month 3
Cigarettes per day reduction greater than 50%
Quit attempts
时间窗: Month 1
Quit attempts since last contact
Quit attempts
时间窗: Month 3
Quit attempts since last contact
Seven-day point prevalence abstinence
时间窗: Month 1
Participant has not had a cigarette in the past 7 days
Seven-day point prevalence abstinence
时间窗: Month 3
Participant has not had a cigarette in the past 7 days
E-visit Acceptability
时间窗: Month 1
The e-visit will be considered acceptable if the average score on the Acceptability of Intervention Measure (AIM) is greater than or equal to 4.
E-visit Acceptability
时间窗: Month 3
The e-visit will be considered acceptable if the average score on the Acceptability of Intervention Measure (AIM) is greater than or equal to 4.
E-visit Adoption
时间窗: Month 1
Patients prescribed a medication who obtain their medication
E-visit Adoption
时间窗: Month 3
Patients prescribed a medication who obtain their medication
次要结局
未报告次要终点
研究者
Jennifer Dahne
Associate Professor
Medical University of South Carolina